ReviseFCPS1
CPSP Part 1 Prep

Typhoid Management Wizard

Step-wise management following the MMIDSP Typhoid Management Guidelines 2022 — Pakistan's own national society guidance, written for a setting with high antimicrobial resistance.

Decision-support only — not a prescription. This reproduces the MMIDSP 2022 guideline. Doses are quoted from its tables; verify every dose against the guideline and your patient's renal function, allergies and weight before prescribing. The prescriber remains responsible.
Clinically reviewed by Dr Syed Usama Hussain, MBBS, BSc · 04 Aug 2026.

Step 1 · Should you suspect typhoid?

MMIDSP 2022 · Presentation

Any patient presenting with fever with no clear focus of infection in an endemic setting, for more than 3 days should be suspected to have typhoid fever.

Fever patternTyphoid fever begins 7–14 days after ingestion of the organism. The fever pattern is stepwise — rising over the course of each day and dropping by the following morning, with peaks and troughs rising progressively over time.

Frequently asked questions

When should typhoid be suspected?

Any patient presenting with fever with no clear focus of infection in an endemic setting, for more than 3 days, should be suspected to have typhoid fever. The guideline also requires you to rule out malaria, dengue and other causes of acute febrile illness of more than 3 days duration.

Can Widal or TyphiDOT diagnose typhoid?

No. The MMIDSP 2022 guideline states that positive serological tests such as Widal and TyphiDOT are not recommended for the diagnosis of enteric fever and are not included in the case definitions of typhoid. It adds that serological tests should never be ordered or relied upon to diagnose or rule out enteric fever. Blood culture is the diagnostic standard.

How many blood cultures should be taken?

Two sets of blood culture are optimal before starting antibiotic therapy, and also in patients already on antibiotics who are not responding. In bacteraemic patients automated cultures can turn positive as early as 4 hours, with final identification and susceptibility in the following 48 hours.

What is XDR typhoid?

Typhoid caused by S. Typhi strains resistant to all recommended antibiotics for typhoid fever — first-line drugs, fluoroquinolones and third-generation cephalosporins — but still sensitive to carbapenems and azithromycin. This is why ceftriaxone fails in many Pakistani patients.

What is the azithromycin dose for XDR typhoid?

For a clinically stable patient, dosed by body weight: under 60 kg, a 1 g oral loading dose followed by 500 mg every 24 hours for 7–10 days; over 60 kg, 1 g every 24 hours. Paediatric dosing is 8–10 mg/kg. If the patient cannot take orally, is haemodynamically unstable, is deteriorating or develops complications, admit or refer and use a carbapenem.

Why does the fever not settle quickly?

Fever defervescence is prolonged in typhoid and may take 5–7 days to improve. The guideline explicitly warns not to rush to change antibiotics — monitor for improvement in the frequency and intensity of fever instead. Appetite and general condition often improve before the fever does.

How long should treatment last?

Most categories require 14 days. For XDR typhoid, azithromycin is given for 7–10 days, or a carbapenem for 10–14 days with de-escalation to oral azithromycin to complete a total of 14 days. For MDR typhoid the guideline warns that shorter cephalosporin courses may lead to relapse.

Which empiric antibiotic should I start?

The guideline states two different empiric regimens in two separate sections — azithromycin or a carbapenem in the Treatment section, and cefixime or ceftriaxone in the Management guidelines section. This tool reproduces both verbatim with their sections and does not choose between them, because in a setting with high XDR prevalence they are not equivalent. Decide based on local resistance patterns and your patient.

How long should patients be followed up?

Despite completion of treatment, patients should be monitored for relapse or complications for 3 months after treatment has commenced.

Clinically reviewed by Dr Syed Usama Hussain, MBBS, BSc
MBBS, BSc — active medical practitioner in Pakistan. Graduated from Federal Medical & Dental College, Islamabad (2021) and completed a one-year clinical internship at the Pakistan Institute of Medical Sciences (PIMS), Islamabad (2022).
Sources

Background reading — why ceftriaxone fails, and the one test the guideline says never to rely on: XDR typhoid in Pakistan.